Mumbai, Jan. 24 -- Zydus Lifesciences announced that the USFDA conducted an inspection at the group's Unit - 2 manufacturing plant at Ankleshwar, Gujarat. The inspection was conducted from 19th to 23rd January, 2026 and concluded with 3 observations. There were no data integrity related observations. The Company will closely work with the USFDA to address the observations expeditiously.

Published by HT Digital Content Services with permission from Capital Market....